How can life science companies apply safety signaling and real-world records to achieve better healthcare outcomes?


Register here: https://globalmeet.webcasts.com/starthere.jsp?ei=1569315&tp_key=da05f61731&sti=oracle 

With Oracle’s recent acquisition of Cerner, new opportunities are emerging for this collaboration to improve the safety of medical products.


Oracle’s market-leading safety software solutions provide highly powerful technology and algorithms for data mining. Combining Cerner Enviza’s real-world datasets containing de-identified, person-centric, longitudinal records offers a vast resource for expanding the potential of safety signaling.

Real world evidence standardization is high on the agenda of most big pharma companies. See how the FDA is setting regulatory frameworks in place, and how Janssen are creating frameworks.
Access it here: http://bit.ly/2S2XRDG

Generating a better understanding of how our medicines work in the real world ultimately allows us to benefit the patients that we serve. As a pioneer in real-world evidence (RWE) in diabetes, Sanofi has been building a large set of real world data for its insulins. Data of this kind helps demonstrate the value that our medicines bring to physicians and patients. Importantly, our RWE program helps evaluate the true effect of basal insulins on severe hypoglycemia. Sanofi has taken an innovative approach to generating this type of evidence, with the use of advanced statistical techniques and big data.